The Open Biochemistry Journal

ISSN: 1874-091X ― Volume 15, 2021

Study on Certain Biomarkers of Inflammation in Psoriasis Through “OMICS” Platforms

C. Rodríguez-Cerdeira*, 1, A. Molares-Vila2, E. Sánchez-Blanco3, B. Sánchez-Blanco4
1 Department of Dermatology, CHUVI and University of Vigo, Vigo, Spain
2 Department of Analytical Chemistry, University of Vigo, Spain
3 Postgraduate researcher, University of Vigo, Vigo, Spain
4 Postgraduate researcher, Department of Emergency, CHUVI, Vigo, Spain



In recent years, research on psoriasis has focused on the identification of biomarkers for the diagnosis, pathogenesis, prognosis, or therapeutic response of the disease. These studies could provide insights into the susceptibility and natural history of psoriasis. The identification of biomarkers related to comorbidities in psoriasis, such as arthritis, cardiovascular disease, and the metabolic syndrome, is of special clinical interest.

Materials and Methods:

We performed an extensive review on psoriasis biomarkers, including cytokine and growth factors, in the literature published between 1997 and 2013, including cross-references of any retrieved articles. We also included some data from our own studies.


This review presents current knowledge of soluble biomarkers in psoriasis, including cytokines, chemokines, proangiogenic mediators, growth factors, antimicrobial proteins, neuropeptides, and oxidative stress markers.


In conclusion, a number of studies have been conducted with the aim of establishing soluble biomarkers for psoriasis. Most of the biomarkers that have been studied do not meet the criteria for a clinically useful biomarker. Further work is needed to establish a role for soluble biomarkers in the diagnosis and treatment of psoriasis, with a special focus on biomarkers for psoriasis comorbidities, such as arthritis, cardiovascular disease, and the metabolic syndrome.

Keywords: : Biomarker, cytokine, growth factor, psoriasis.

Article Information

Identifiers and Pagination:

Year: 2014
Volume: 8
First Page: 21
Last Page: 34
Publisher Id: TOBIOCJ-8-21
DOI: 10.2174/1874091X01408010021

Article History:

Received Date: 20/10/2013
Revision Received Date: 11/12/2013
Acceptance Date: 14/12/2013
Electronic publication date: 21/2/2014
Collection year: 2014

© Rodríguez-Cerdeira et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Department of Dermatology. CHUVI and University of Vigo, Vigo. Spain; Tel: 0034600536114; Fax: 0034986276416; E-mails:;

Track Your Manuscript:


"We have always had a fruitful cooperation and long-term experience of publishing with Bentham Open."

"A number of our original papers have appeared in its different journals, as the Bentham Open Publishers provides sufficient research in the field of science and technologies (belonging to the pharmaceutical, biotechnology, biomedical industries etc). The staff of the Bentham Open always treat our papers very seriously and gently during the rutile paper reviewing process, so far we always felt their kindness and highly cooperative support. Today, Bentham Open is providing a great support to science and research, giving opportunities of high standard publishing as well as promoting and enhancing selected papers around the world through communication and exchange of global scientific education."

Kholmirzo T. Kholmurodov
Leading Scientist
FLNP (Frank Laboratory of Neutron Physics) JINR (Joint Institute of Nuclear Research) Moscow region, Russia

Browse Contents

Webmaster Contact:
Copyright © 2021 Bentham Open